Literature DB >> 16709344

Congenital nasolacrimal duct obstruction.

Caroline J Macewen1.   

Abstract

Congenital nasolacrimal duct obstruction is a common disorder in infants, with up to 20% of all newborns suffering from epiphora during the first year of life. This paper reviews the current evidence regarding the incidence, natural history, and management of congenital nasolacrimal duct obstruction. It highlights the role of nasendoscopy in improving the understanding of the condition, which has resulted in better overall management.

Entities:  

Mesh:

Year:  2006        PMID: 16709344

Source DB:  PubMed          Journal:  Compr Ophthalmol Update        ISSN: 1527-7313


  5 in total

1.  Transcanalicular endoscopic primary dacryoplasty for congenital nasolacrimal duct obstruction.

Authors:  Nozomi Matsumura; Toru Suzuki; Satoshi Goto; Takeshi Fujita; Shin Yamane; Maiko Maruyama-Inoue; Kazuaki Kadonosono
Journal:  Eye (Lond)       Date:  2019-02-19       Impact factor: 3.775

2.  Efficacy of probing for children with congenital nasolacrimal duct obstruction: a retrospective study using fluorescein dye disappearance test and lacrimal sac echography.

Authors:  Piero Steindler; Enrico Mantovani; Carlo Incorvaia; Francesco Parmeggiani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-24       Impact factor: 3.117

3.  Clinical Outcome of Probing in Infants with Acute Dacryocystitis - A Prospective Study.

Authors:  Bhawesh Chandra Saha; Rashmi Kumari; Bibhuti Prasanna Sinha
Journal:  J Clin Diagn Res       Date:  2017-08-01

4.  Success rate of probing for congenital nasolacrimal duct obstruction at various ages.

Authors:  Semi Perveen; Aalia Rasool Sufi; Sabia Rashid; Afroz Khan
Journal:  J Ophthalmic Vis Res       Date:  2014-01

5.  Outcomes and comparison of nasolacrimal probing for patients older than 12 months.

Authors:  Kürsad Ramazan Zor; Erkut Küçük; Zeynep Yılmaz Öztorun
Journal:  Ther Adv Ophthalmol       Date:  2020-06-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.